You Lu

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Locally Advanced

Radiation Therapy

Advanced Non Small Cell Lung Cancer

Top Venues

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Meijuan Huang, Yongmei Liu, Min Yu, Yanying Li, Yan Zhang, Jiang Zhu, Li Li, You Lu
A phase I study of the tyrosine kinase inhibitor anlotinib combined with platinum/pemetrexed-based chemotherapy in untreated nonsquamous non-small-cell lung cancer. Investigational new drugs (2021)
Meijuan Huang, Youling Gong, Jiang Zhu, Yi Qin, Feng Peng, Li Ren, Zhenyu Ding, Yongmei Liu, Chengzhi Cai, Yongsheng Wang, You Lu
A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC. Investigational new drugs 38 (2) (2019)
Guodong Huang, Limei Yin, Jie Lan, Ruizhan Tong, Mengqian Li, Feifei Na, Xianming Mo, Chong Chen, Jianxin Xue, You Lu
Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer. Cancer science 109 (7) (2018)